Enovis (ENOV) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -55.33% |
| Dec 31, 2025 | -28.72% |
| Oct 3, 2025 | -77.44% |
| Jul 4, 2025 | 5.03% |
| Apr 4, 2025 | -35.70% |
| Dec 31, 2024 | -67.99% |
| Sep 27, 2024 | -81.60% |
| Jun 28, 2024 | -39.36% |
| Mar 29, 2024 | -32.37% |
| Dec 31, 2023 | -7.29% |
| Sep 29, 2023 | -25.31% |
| Jun 30, 2023 | -20.31% |
| Mar 31, 2023 | -22.79% |
| Dec 31, 2022 | 54.30% |
| Sep 30, 2022 | -26.46% |
| Jul 1, 2022 | 13.57% |
| Apr 1, 2022 | -22.33% |
| Dec 31, 2021 | -19.67% |
| Oct 1, 2021 | -19.04% |
| Jul 2, 2021 | -22.10% |
| Apr 2, 2021 | -1.96% |
| Dec 31, 2020 | -92.31% |
| Oct 2, 2020 | 0.94% |
| Jul 3, 2020 | -19.17% |
| Apr 3, 2020 | -19.55% |
| Dec 31, 2019 | -9.39% |
| Sep 27, 2019 | -52.93% |
| Jun 28, 2019 | -36.61% |
| Mar 29, 2019 | -17.70% |
| Dec 31, 2018 | -31.64% |
| Sep 28, 2018 | -22.79% |
| Jun 29, 2018 | -16.90% |
| Mar 30, 2018 | -5.04% |
| Dec 31, 2017 | -45.02% |
| Sep 29, 2017 | 17.68% |
| Jun 30, 2017 | 12.25% |
| Mar 31, 2017 | 26.05% |
| Dec 31, 2016 | 51.65% |
| Sep 30, 2016 | 65.12% |
| Jul 1, 2016 | 33.38% |
| Apr 1, 2016 | 32.86% |
| Dec 31, 2015 | -18.18% |
| Sep 25, 2015 | 37.50% |
| Jun 26, 2015 | 91.34% |